# Ghrelin and Insulin Resistance

> **NCT00884494** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Obesity
- Insulin Resistance
- Normal Weight,Healthy Controls

## Interventions

- **DRUG:** Ghrelin infusion to assess effects on insulin sensitivity

## Key facts

- **NCT ID:** NCT00884494
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884494, "Ghrelin and Insulin Resistance". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00884494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*